Optimization of the heterologous expression and purification of Plasmodium falciparum generative cell specific 1 in Escherichia coli

MA Meigouni, AA Mehrizi, A Fazaeli, S Zakeri… - Protein Expression and …, 2022 - Elsevier
Abstract Generative cell specific 1 (GCS1) or Hapless2 (Hap2) is a main transmission-
blocking vaccine (TBV) candidate against malaria. Experience has shown that this protein is …
被引用次数：4 相关文章

Optimization of the heterologous expression and purification of Plasmodium falciparum generative cell specific 1 in Escherichia coli

MA Meigouni, AA Mehrizi, A Fazaeli… - Protein expression …, 2022 - pubmed.ncbi.nlm.nih.gov
Generative cell specific 1 (GCS1) or Hapless2 (Hap2) is a main transmission-blocking
vaccine (TBV) candidate against malaria. Experience has shown that this protein is difficult …

Optimization of the heterologous expression and purification of Plasmodium falciparum generative cell specific 1 in Escherichia coli.

A Fazaeli, S Zakeri, ND Djadid - Protein Expression and …, 2022 - europepmc.org
Generative cell specific 1 (GCS1) or Hapless2 (Hap2) is a main transmission-blocking
vaccine (TBV) candidate against malaria. Experience has shown that this protein is difficult …